Myelodysplastic syndrome

Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Characteristics, mutational associations and prognostic implications of clonal events in SF3B1 mutant myeloid neoplasms.
Fig. 2: The clonal trajectories of SF3B1 mutations.


  1. 1.

    Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.

    CAS  Article  Google Scholar 

  2. 2.

    Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478:64–69.

    CAS  Article  Google Scholar 

  3. 3.

    Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N. Engl J Med. 2011;365:1384–95.

    CAS  Article  Google Scholar 

  4. 4.

    Visconte V, Makishima H, Jankowska A, Szpurka H, Traina F, Jerez A, et al. SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia. 2012;26:542–5.

    CAS  Article  Google Scholar 

  5. 5.

    Malcovati L, Karimi M, Papaemmanuil E, Ambaglio I, Jädersten M, Jansson M, et al. SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood. 2015;126:233–41.

    CAS  Article  Google Scholar 

  6. 6.

    Malcovati L, Stevenson K, Papaemmanuil E, Neuberg D, Bejar R, Boultwood J, et al. SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - a Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM). Blood. 2020;136:157–70.

    CAS  Article  Google Scholar 

  7. 7.

    Nagata Y, Makishima H, Kerr CM, Przychodzen BP, Aly M, Goyal A, et al. Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes. Nat Commun. 2019;10:5386.

    Article  Google Scholar 

  8. 8.

    Awada H, Nagata Y, Goyal A, Asad MF, Patel B, Hirsch CM, et al. Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia. Blood Adv. 2019;3:339–49.

    CAS  Article  Google Scholar 

  9. 9.

    Taylor J, Mi X, North K, Binder M, Penson A, Lasho T, et al. Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms. Blood. 2020;136:1477–86.

    Article  Google Scholar 

  10. 10.

    Obeng E, Chappell R, Seiler M, Chen MC, Campagna DR, Schmidt PJ, et al. Physiologic expression of Sf3b1(K700E) causes impaired erythropoiesis, aberrant splicing, and sensitivity to therapeutic spliceosome modulation. Cancer Cell. 2016;30:404–17.

    CAS  Article  Google Scholar 

Download references


We thank the following sources of funding: Aplastic Anemia and MDS International Foundation Research Grant (VV and JPM), Vera and Joseph Dresner Foundation-MDS Research Fund (VV), VeloSano Pilot Award (VV), NIH/NHLBI R35HL135795 (JPM), R01HL132071 (JPM), The Henry and Marilyn Taub Foundation (JPM). We thank the team of Mission Bio for technical expertise on single cell-DNA sequencing and The Cancer Genome Atlas (TCGA), The BEAT AML Master Trial and The German-Austrian Study Group for data accessibility.

Author information




Contribution: HA collected, analyzed and interpreted the data, designed the tables and figures, and wrote the manuscript; CMK, AD developed DNA-sequencing methodologies, analyzed single cell-DNA sequencing, and edited the manuscript; VA; CG, SP, MZ, SK, collected the data and edited the manuscript; HJR collected clinical info and provided critical review to the manuscript; YS, MAS, HEC provided patients and important insights to the manuscript preparation; JPM provided patients, laboratory space and facilities, granted a collection of clinical charts and molecular annotated databases, sponsored the DNA sequencing studies, and edited the manuscript; VV conceived the idea, designed the study, supervised the work, interpreted and analyzed the data and content, and wrote the manuscript.

Corresponding author

Correspondence to Valeria Visconte.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Awada, H., Kerr, C.M., Durmaz, A. et al. Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations. Leukemia (2021).

Download citation


Quick links